TY  - CHAP
M1  - Book, Section
TI  - Risk Assessment and Clinical Management – Ovarian Cancer
A1  - Zeybek, Burak
A1  - Ratner, Elena
A2  - Llor, Xavier
A2  - Hofstatter, Erin Wysong
Y1  - 2022
N1  - 
T2  - Cancer Genetics: A Clinical Approach
AB  - Ovarian  cancer  is  the  second  most  common  gynecologic  malignancy  and  the  most  common  cause  of  death  from  gynecologic  cancer  in  the  United  States  with  22,240  new  cases  and  14,000  deaths  annually.1  It  is  the  fifth  leading  cause  of  cancer  death  in  women  after  cancers  of  the  breast,  lung,  and  endometrium.  Based  on  the  National  Cancer  Database  Surveillance,  Epidemiology,  and  End  Results  (SEER)  data  from  2011  to  2015,  the  lifetime  risk  of  developing  ovarian  cancer  is  1.3%,  and  the  median  age  at  diagnosis  is  63.  The  number  of  new  cases  and  deaths  are  reported  to  be  11.6  and  7.2  per  100,000  women  per  year,  respectively.2  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/18
UR  - hemonc.mhmedical.com/content.aspx?aid=1182365823
ER  -